Summary DNA measurements on biopsy material from 24 squamous cell carcinomas of the oral cavity given preoperative radiotherapy indicate that DNA aneuploid tumours respond better to radiotherapy than do diploid and polyploid tumours. The mean S-phase value was higher (16.1%) for 8 tumours that were eradicated by preoperative radiotherapy than for 13 that did not respond (8.1%). These factors correlated better with the response than did histological and clinical (T) classifications.
It is well known that tumours of similar macroand microscopical appearance do not always respond similarly to radiotherapy. An objective predictor of the irradiation response would be of great value when planning the treatment.
Reduction in tumour volume has been used as a prognostic criterion in radiotherapy (Grossman et al., 1973; Mantyla et al., 1979) . The regression rate after 40-45Gy of irradiation is assumed to be important when deciding whether to continue radiotherapy or to change treatment modality (Lederman, 1972) . It has, however, been proposed that this decision can be made already after 1OGy, a clinical regression of more than 10% being considered an indicator of radioresponsiveness (Arcangeli et al., 1980) . The correlation between reduction in size and response to radiotherapy does not apply to tumours with different histology and site, and does not always hold for tumours with the same histology and site, such as squamous cell carcinomas of categories T3-T4 arising within the head and neck (Friedman, 1974) .
A decrease in thymidine labelling index (LI) by more than 60% of the pretreatment value after 15 Gy within 10 days has been said to be a good prognostic indicator (Fettig et al., 1973) . The same figures were reported by Molinari et al. (1984) , who noted a higher complete regression rate in patients whose tumour proliferative activity was reduced by 70% or more after 1OGy of radiotherapy. Another interesting finding was the correlation between LI reduction and long-term response. However, opinions vary: Courdi and co-workers (1980) observed the reverse relation between LI reduction and tumour regression during radiotherapy and 5-year survival.
DNA measurements have been used to predict response to radiotherapy. Rutgers (1985) found that determinations of the ploidy level of the main cell line in a tumour can complement the histological classification and add to the understanding of in vivo irradiation effects in human tumours. In 15 squamous cell carcinomas of the uterine cervix, Lin et al. (1984) found that radioresistent cells were non-cycling DNA diploid cells; they found that the mean value of the 2c cell population before irradiation may be used as a parameter to foretell radiosensitivity.
The aim of the present study was to see whether determinations of DNA ploidy and S-phase in diagnostic biopsy specimens from oral cavity carcinomas could assist in predicting the responsiveness to preoperative radiotherapy.
Material and methods Material Biopsy specimens from 24 patients with squamous cell carcinomas of the oral cavity taken for routine histopathological examination during 1978-1983 were studied. In addition the operation specimens were examined. All except one patient had received [40] [41] [42] [43] [44] Gy of preoperative radiotherapy.
Irradiation technique Irradiation was accomplished using 4 or 6 MV linear accelerator. The target volume included primary tumour and uni-or bilateral neck nodes depending on primary tumour location. The treatment technique included anterior and one or two lateral oblique fields with wedge filters. The target absorbed doses are shown in Table I . CTscans, in at least three levels of the treatment volume, were used as a basis for the dose planning. Intra-oral and oesophageal thermoluminescence dosimetry (TLD) measurments were performed routinely to confirm calculated target absorbed doses. Selected tumour areas in 50tim-thick sections from the formalin-fixed, paraffin-embedded blocks were prepared as described by Hedley et al. (1983) , except that the specimens were cytocentrifuged onto object glasses and stained with Hoechst 33258. Twenty-four preradiological and 16 postradiological specimens were prepared; in 8 specimens no tumour remained after radiotherapy.
Histopathological examination All specimens were examined by the same pathologist. The biopsy specimens of the squamous cell carcinomas were re-examined and classified as well, moderately well, and poorly differentiated on the basis of the cytological and structural picture. Sections from the operation specimens were also re-examined. Specimens with only fibrosis, inflammation, and foreign body reaction were classified as 'no remaining tumour'. In specimens with remaining tumour, evaluation of the rate of response to radiotherapy was based on the least degenerated part of the tumour, and was graded into 'no' or 'moderate response'. In 'moderate response', nuclear pyknosis, cytoplasmic vacuolization, and no signs of mitosis should be present, and should contrast with the findings in the primary biopsy material.
DNA measurements
Static cytophotometry was performed using a Leitz MPV 3 cytophotometer and the Fluora programme (Bjelkenkrantz et al., 1983) . About 300 tumour nuclei and 10-20 lymphocytes were measured in each specimen.
DNA classification
From the histograms the following were evaluated. and G2/M peaks were calculated manually, when the GO/1 and G2/M peaks had been defined, and divided by the total numbers of nuclei in GO/1 +S-phase+G2/M. In DNA polyploid tumours, the S-phase was determined by looking at the cell population between the DNA diploid and tetraploid peaks. In DNA aneuploid tumours, the S-phase was subjectively estimated taking an overlapping DNA diploid G2/M peak into account.
Results
The DNA histograms of the 24 squamous cell carcinomas were classified into 5 DNA diploid ( Figure 6 ). In addition, moderate response to radiotherapy was noted in 2 of the DNA polyploid tumours and in 1 of the DNA aneuploid (Table II) . The mean S-phase was 6.4% (2-14) for the DNA diploid, 10.0% (1-30) for the DNA polyploid, and 19.1% (10-29) for the DNA aneuploid tumours. The mean S-phase value for the group of tumours eradicated by radiotherapy was 16.1% (3-29), and 8.1% (1-16) for those that did not respond. The were well differentiated, 6 moderately well differentiated, and 1 poorly differentiated. Of the 7 DNA aneuploid tumours 3 were well differentiated, 3 moderately well differentiated, and 1 poorly differentiated. Of the 8 carcinomas eradicated by preoperative radiotherapy 5 were well differentiated and 3 moderately well differentiated (Table III) .
In accordance with the TNM classification (UICC, 1978) the following emerged. Of the 5 DNA diploid tumours 3 were T2 and 2 T4; 3 had lymph-node metastases. The 12 DNA polyploid tumours comprised 1 TI and 7 T2, 3 T3 and 1 T4; 6 had lymph-node metastases. The 7 DNA aneuploid tumours comprised 5 T2, 1 T3, and 1 T4; 4 had lymph-node metastases. Two of the 4 T4 tumours involved bone, and were therefore not only classified according to size.
The tumours eradicated by radiotherapy Moderately differentiated weeks after preoperative radiotherapy (44 Gy), the remaining tumour shows minimal response to radiotherapy (H&E, bar: 50pm), and the DNA pattern is unchanged. (Fettig et al., 1973; Courdi et al., 1980; Molinari et al., 1984; Klintenberg et al., 1985) , and DNA determination before, during, and after radiotherapy (Ganzer, 1974; Lin et al., 1984; Rutgers, 1985) . Inherent characteristics of cells form an important basis for differences in radiosensitivity. Other factors include oxygenation, radiation damage repair potential, growth and proliferation rates, variation in radiosensitivity during the cellcycle, and fractionation pattern. Tumour heterogeneity assumes the existence of subpopulations of cells with different geno-and phenotypes resulting in cell clones with characteristic radiosensitivity, and is considered a major problem in the search for clinically reliable cell kinetic criteria (Friedman, 1975) . Molinari et al. (1984) found that a decrease in thymidine labelling index (LI) by 70% or more after a 5-day course of radiotherapy (10 Gy) resulted in a higher rate of complete regression. This reduction in LI corresponded to an 82% 3-year disease-free survival, whereas all tumours recurred within 19 months in patients in whom no such LI reduction took place.
DNA measurements are superior to LI estimations in that both DNA ploidy, S-phase, and the occurrence of hypertetraploid nuclei can be determined. Ganzer (1974) Rutgers (1985) indicate that determination of the ploidy level of the main cell line in a tumour can complement the histological classification, and that the mean value of the 2c cell population before irradiation could prove to be a clinically useful predictor of radiosensitivity. Trott (1980) stressed two major difficulties in determining the response to radiotherapy during the course of treatment.
1. After one-third of the treatment period more than 99% of the remaining tumour consists of doomed cells. It therefore seems impossible toassess the therapeutic response from biopsy material removed during the course of radiotherapy. 2. The heterogeneity of tumours makes it difficult to obtain identical biopsy specimens on repeated sampling.
In the present study we have evaluated pretreatment biopsy material and operation specimens obtained 4 weeks after completion of the preoperative radiotherapy to avoid some of the above mentioned problems.
The method of disintegrating nuclei from formalin-fixed, paraffin-embedded material described by Hedley et al. (1983) , allows the retrospective study of adequate histopathological material from patients in whom the clinical outcome is known. DNA aneuploid tumours apparently responded better to radiotherapy than did DNA polyploid and DNA diploid tumours (Table II) . Accurate S-phase determinations are difficult using static cytofluorometry as the number of nuclei measured is limited. The S-phase was higher in the aneuploid tumours. The mean S-phase value was also higher in tumours that responded well to radiotherapy (16.1%) than in those that did not respond (8.1%). These figures tally with those of Nusse (1981) , who found the cells in the late S-phase and the G2/M-phase to be those most susceptible to radiotherapy. DNA aneuploid tumours and a high S-phase are closely correlated which makes it difficult to evaluate which of these parameters has the greatest influence on the radiosensitivity. The estimation of the S-phase in DNA polyploid tumours is difficult as it is impossible to separate a DNA diploid tumour with prolonged G2-phase and a DNA tetraploid tumour. Cell doublets counted as a G2-phase or a tetraploid peak can, however, be ruled out as the measurements are performed under visual control, which is the strength of static cytofluorometry versus flow cytometry. According to Molinari et al. (1984) , the GO/Gl-phase is the period of the cell cycle that has the longest duration (from hours to months); this could be an alternative explanation for the lower responsiveness of the diploid tumours. An interesting finding was that of the 8 squamous cell carcinomas that were eradicated by preoperative radiotherapy, 5 were well differentiated (Figures 2, 4, 6 ) and 3 moderately well differentiated. The two poorly differentiated tumours (which could be assumed to be the most radiosensitive) did not respond, at least not as assessed histologically (Figure 5 ).
The size of the tumours and the presence of lymph-node metastases did not apparently correlate with the rate of response. There was no major difference in size between the tumours that responded to radiotherapy and those that did not. There was an equal incidence of lymph-node ..11 I metastases (-50% in each group) in the group that responded well to radiotherapy and in the group that showed no response. The present pilot study indicates that DNA analysis may yield clinically applicable information concerning response to radiotherapy. Further investigations on a larger series of squemous cell carcinomas of the head and neck is currently performed, to see if the findings now presented can be confirmed.
